In the decades since the first AIDS cases were reported in Los Angeles and New York City in 1981, the epicenter of the nation’s HIV epidemic has shifted from urban centers along the coasts to the 16 states and District of Columbia that make up the South. The South now experiences the greatest burden of … Read more

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention. Scientists in the UNC School of Medicine’s Division of Infectious Diseases and the UNC Eshelman School of Pharmacy are developing an … Read more

The editors of PLOS Medicine are delighted to announce a forthcoming Special Issue focused on HIV research, along with guest editors Drs Linda-Gail Bekker, Steven Deeks and Sharon Lewin. Submissions are now being invited, with a deadline of June 9, 2017. PLOS Medicine, the leading open access medical journal published by PLOS, welcomes submission of … Read more

The HIV Prevention Trials Network (HPTN) announced that the final results of the HPTN 052 study were published in the New England Journal of Medicine (NEJM). This pivotal study demonstrated that antiretroviral therapy (ART) for HIV infection provides durable and reliable protection against the sexual transmission of the virus from infected men and women to their HIV-uninfected … Read more

Our understanding of human immunodeficiency virus (HIV) has come a long way since it was first named in 1986. Yet little of this new information about the virus, which still infects 50,000 new people each year in the United States, seems to have made its way into the general public. A research project out of UNC called 2BeatHIV is … Read more

UNC School of Medicine’s Anne Lyerly is addressing the urgent need for effective HIV prevention and treatment for the estimated 1.5 million women worldwide with HIV who give birth each year. With a $3 million NIH grant, Dr. Lyerly is leading an interdisciplinary team of researchers to determine what barriers prevent investigators from studying the virus in pregnant women. Lyerly, associate … Read more

Antiretroviral therapy (ART) for HIV infection provides consistent protection against the sexual transmission of the HIV virus from infected men and women to their HIV-uninfected sexual partners. These findings were announced on Monday, July 20 by researcher Dr. Myron Cohen at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment & Prevention in Vancouver, Canada. Cohen, … Read more

The New Yorker recently featured the research of UNC School of Medicine researcher David Margolis, MD, in this article about the search for a cure to HIV infection. Margolis, a professor of medicine, epidemiology, and microbiology and immunology, serves as director of the School of Medicine’s Program in Translational Clinical Research. Dr. Margolis currently leads … Read more

Five abstracts from UNC CFAR have been accepted for presentation at the poster session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, each of which were supported by the UNC CFAR’s Biostatistics Core. This annual collaborative science conference brings together top basic, translational, and clinical researchers from around the world to share the latest … Read more